High-grade endometrial stromal sarcoma after treatment with tamoxifen in a patient treated for breast cancer
- 1 September 2003
- journal article
- case report
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 13 (5) , 690-692
- https://doi.org/10.1046/j.1525-1438.2003.13308.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tamoxifen treatment and gynecologic side effects: a reviewPublished by Wolters Kluwer Health ,2004
- Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 2000
- Endometrial Stromal Sarcoma With Sex Cord–Like Differentiation Associated With Tamoxifen TherapySouthern Medical Journal, 1998
- Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control studyInternational Journal of Cancer, 1998
- Endolymphatic Stromal Myosis Associated with Tamoxifen UseGynecologic Oncology, 1997
- Uterine stromal sarcoma following tamoxifen treatment.Journal of Clinical Pathology, 1995
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Steroid Hormone Receptors in Endometrial Stromal Sarcomas: A Biochemical and Immunohistochemical StudyAmerican Journal of Clinical Pathology, 1992
- Uterine sarcoma: Steroid receptors and response to hormonal therapyGynecologic Oncology, 1990
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989